Evolving neoantigen profiles in colorectal cancers with DNA repair defects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evolving neoantigen profiles in colorectal cancers with DNA repair defects

Published:2019-06-28 Issue:1 Volume:11 Page:
ISSN:1756-994X
Container-title:Genome Medicine
language:en
Short-container-title:Genome Med

Author:

Rospo Giuseppe,Lorenzato Annalisa,Amirouchene-Angelozzi Nabil,Magrì Alessandro,Cancelliere Carlotta,Corti Giorgio,Negrino Carola,Amodio Vito,Montone Monica,Bartolini Alice,Barault Ludovic,Novara Luca,Isella Claudio,Medico Enzo,Bertotti Andrea,Trusolino Livio,Germano Giovanni,Di Nicolantonio Federica,Bardelli Alberto^ORCID

Funder

European Community’s Seventh Framework Programme

AIRC IG program

AIRC Special Program 5 per mille metastases Project

Fondazione Piemontese per la Ricerca sul Cancro-ONLUS, 5 × 1,000 Ministero della Salute

Fondo per la Ricerca Locale (ex 60%), Università di Torino

European Community’s H2020

Ministero della Salute

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13073-019-0654-6.pdf

Reference53 articles.

1. Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182–91.

2. Gibney GT, Weiner LM, Atkins MB. Predictive biomarkers for checkpoint inhibitor-based immunotherapy. Lancet Oncol. 2016;17(12):e542–e51.

3. Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350–5.

4. Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science. 2018;362(6411):1–10.

5. Lee CH, Yelensky R, Jooss K, Chan TA. Update on tumor neoantigens and their utility: why it is good to be different. Trends Immunol. 2018;39(7):536–48.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors;npj Precision Oncology;2024-09-05

2. Mutational Signatures in Colorectal Cancer: Translational Insights, Clinical Applications, and Limitations;Cancers;2024-08-24

3. A pan-cancer interrogation of intronic polyadenylation and its association with cancer characteristics;Briefings in Bioinformatics;2024-07-25

4. Mutational signatures of colorectal cancers according to distinct computational workflows;Briefings in Bioinformatics;2024-05-23

5. Tissue and cellular spatiotemporal dynamics in colon aging;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3